https://news.medxy.ai/zh/leukemia-immunotherapy/Medxy AIzh2026-09-28T06:05:15-07:00超越传统靶点：急性髓系白血病精准免疫治疗的新进展 https://news.medxy.ai/ja/precision-immunotherapy/Medxy AIja2026-09-28T06:04:56-07:00急性骨髄性白血病における精密免疫療法：従来標的を超えて https://news.medxy.ai/vi/precision-immunotherapy-in-leukemia/Medxy AIvi2026-09-28T06:04:36-07:00Liệu pháp miễn dịch chính xác trong bạch cầu cấp dòng tủy: Vượt ra ngoài các mục tiêu truyền thống https://news.medxy.ai/precision-immunotherapy-in-acute-myeloid-leukemia-advancing-beyond-traditional-targets/Medxy AIen2026-09-28T06:04:15-07:00Precision Immunotherapy in Acute Myeloid Leukemia: Advancing Beyond Traditional Targets https://news.medxy.ai/zh/mertk-cll-strategy-2/Medxy AIzh2026-09-28T06:03:34-07:00靶向CLL中的MERTK：克服ibrutinib耐药的潜在新策略 https://news.medxy.ai/ja/mertk-targeting-cll/Medxy AIja2026-09-28T06:03:17-07:00CLLにおけるMERTK標的化：Ibrutinib耐性を克服する有望な戦略 https://news.medxy.ai/vi/mertk-cll-strategy/Medxy AIvi2026-09-28T06:02:58-07:00Nhắm đích MERTK trong CLL: Chiến lược đầy hứa hẹn để vượt qua tình trạng kháng ibrutinib https://news.medxy.ai/targeting-mertk-in-cll-a-promising-strategy-for-overcoming-ibrutinib-resistance/Medxy AIen2026-09-28T06:02:37-07:00Targeting MERTK in CLL: A Promising Strategy for Overcoming Ibrutinib Resistance https://news.medxy.ai/zh/adamts13-treatment-benefits/Medxy AIzh2026-09-28T06:02:00-07:00重组ADAMTS13治疗在先天性血栓性血小板减少性紫癜中疗效与安全性优于血浆治疗：3期试验最终结果 https://news.medxy.ai/ja/adamts13-therapy-results/Medxy AIja2026-09-28T06:01:41-07:00先天性TTPに対する組換えADAMTS13療法、血漿療法を上回る有効性と安全性を示す：第3相試験最終結果 https://news.medxy.ai/vi/adamts13-recombinant-benefits/Medxy AIvi2026-09-28T06:01:20-07:00ADAMTS13 tái tổ hợp cho thấy hiệu quả và độ an toàn vượt trội so với liệu pháp huyết tương trong TTP bẩm sinh: Kết quả cuối cùng của thử nghiệm pha 3 https://news.medxy.ai/recombinant-adamts13-therapy-demonstrates-superior-efficacy-and-safety-over-plasma-based-therapy-in-congenital-thrombotic-thrombocytopenic-purpura-final-phase-3-trial-results/Medxy AIen2026-09-28T06:01:01-07:00Recombinant ADAMTS13 Therapy Demonstrates Superior Efficacy and Safety Over Plasma-Based Therapy in Congenital Thrombotic Thrombocytopenic Purpura: Final Phase 3 Trial Results https://news.medxy.ai/zh/srage-ards-lung-recruitment/Medxy AIzh2026-09-28T06:00:24-07:00血浆sRAGE生物标志物助力ARDS个体化肺复张：基于LIVE试验的研究解读 https://news.medxy.ai/ja/plasma-srage-ards/Medxy AIja2026-09-28T06:00:04-07:00血漿sRAGEバイオマーカーがARDSの個別化肺リクルートメント戦略を導く：LIVE試験からの知見 https://news.medxy.ai/vi/srage-plasma-ards/Medxy AIvi2026-09-28T05:59:43-07:00sRAGE huyết tương: chỉ dấu định hướng chiến lược tuyển mộ phổi cá thể hóa trong ARDS từ thử nghiệm LIVE https://news.medxy.ai/plasma-srage-biomarker-guides-personalized-lung-recruitment-strategies-in-ards-insights-from-the-live-trial/Medxy AIen2026-09-28T05:59:22-07:00Plasma sRAGE Biomarker Guides Personalized Lung Recruitment Strategies in ARDS: Insights from the LIVE Trial https://news.medxy.ai/zh/inhaled-treprostinil-ipf-2/Medxy AIzh2026-09-28T05:58:46-07:00吸入性 Treprostinil 在特发性肺纤维化中的应用：TETON-1 与 TETON-2 Ⅲ期联合试验的有力证据 https://news.medxy.ai/ja/treprostinil-ipf-trials/Medxy AIja2026-09-28T05:58:30-07:00特発性肺線維症に対する吸入用Treprostinil：TETON-1・TETON-2第3相試験統合解析が示す確かなエビデンス https://news.medxy.ai/vi/inhaled-treprostinil-ipf/Medxy AIvi2026-09-28T05:58:13-07:00Treprostinil dạng hít trong xơ phổi vô căn: Bằng chứng vững chắc từ phân tích gộp hai thử nghiệm giai đoạn 3 TETON-1 và TETON-2 https://news.medxy.ai/inhaled-treprostinil-in-idiopathic-pulmonary-fibrosis-robust-evidence-from-the-combined-teton-1-and-teton-2-phase-3-trials/Medxy AIen2026-09-28T05:57:56-07:00Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: Robust Evidence from the Combined TETON-1 and TETON-2 Phase 3 Trials https://news.medxy.ai/zh/hess-screen-test/Medxy AIzh2026-09-28T05:57:15-07:00Hess屏幕试验：区分去代偿性内隐斜与眼睑下垂综合征的关键工具 https://news.medxy.ai/ja/esophoria-eye-syndrome/Medxy AIja2026-09-28T05:57:00-07:00Hess Screen Testで見抜く：decompensated esophoriaとsagging eye syndromeの鑑別 https://news.medxy.ai/vi/hess-screen-test-2/Medxy AIvi2026-09-28T05:56:42-07:00Hess Screen Test: Công cụ then chốt để phân biệt lé ẩn trong trạng thái mất bù với hội chứng mắt sa trễ https://news.medxy.ai/hess-screen-test-a-crucial-tool-to-differentiate-decompensated-esophoria-from-sagging-eye-syndrome/Medxy AIen2026-09-28T05:56:22-07:00Hess Screen Test: A Crucial Tool to Differentiate Decompensated Esophoria from Sagging Eye Syndrome https://news.medxy.ai/ja/botulinum-toxin-throat/Medxy AIja2026-09-28T05:55:46-07:00声門上ボツリヌス毒素注射が喉頭感覚障害の症状を改善 https://news.medxy.ai/vi/botulinum-toxin-treatment/Medxy AIvi2026-09-28T05:55:29-07:00Tiêm Botulinum Toxin vùng trên thanh môn giúp cải thiện triệu chứng rối loạn cảm giác thanh quản https://news.medxy.ai/supraglottic-botulinum-toxin-injection-improves-symptoms-of-laryngeal-sensory-dysfunction/Medxy AIen2026-09-28T05:55:11-07:00Supraglottic Botulinum Toxin Injection Improves Symptoms of Laryngeal Sensory Dysfunction https://news.medxy.ai/zh/risk-benefit-balance-3/Medxy AIzh2026-09-28T05:54:37-07:00风险与获益如何平衡：双侧输卵管卵巢切除术时机对 BRCA1/2 突变携带者卵巢癌风险的影响 https://news.medxy.ai/ja/brca1-2-ovarian-cancer-risk/Medxy AIja2026-09-28T05:54:21-07:00BRCA1/2変異保有者における卵巣癌リスク：両側卵管卵巣摘出術の実施時期はどう影響するか https://news.medxy.ai/vi/ovary-tube-removal-risk/Medxy AIvi2026-09-28T05:54:02-07:00Cắt bỏ hai bên vòi trứng và buồng trứng: thời điểm phẫu thuật ảnh hưởng thế nào đến nguy cơ ung thư buồng trứng ở người mang đột biến BRCA1/BRCA2? https://news.medxy.ai/balancing-risks-the-impact-of-bilateral-salpingo-oophorectomy-timing-on-ovarian-cancer-risk-in-brca1-and-brca2-mutation-carriers/Medxy AIen2026-09-28T05:53:45-07:00Balancing Risks: The Impact of Bilateral Salpingo-Oophorectomy Timing on Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers https://news.medxy.ai/zh/tia-dementia-risk/Medxy AIzh2026-09-28T05:53:11-07:00TIA后的长期痴呆风险：一项人群研究揭示持续性的认知威胁 https://news.medxy.ai/ja/tia-dementia-risk-2/Medxy AIja2026-09-28T05:52:52-07:00TIA後の認知症リスクは長期に持続するのか：人口ベース研究が示した持続的な認知的脅威 https://news.medxy.ai/vi/long-term-dementia-risk-after-tia/Medxy AIvi2026-09-28T05:52:33-07:00Nguy cơ sa sút trí tuệ dài hạn sau TIA: Nghiên cứu dựa trên quần thể cho thấy mối đe dọa nhận thức kéo dài https://news.medxy.ai/long-term-dementia-risk-after-tia-a-population-based-study-reveals-sustained-cognitive-threat/Medxy AIen2026-09-28T05:52:13-07:00Long-Term Dementia Risk After TIA: A Population-Based Study Reveals Sustained Cognitive Threat https://news.medxy.ai/vi/semaglutide-heart-benefits/Medxy AIvi2026-09-28T05:50:52-07:00Semaglutide và lợi ích tim mạch: Giải mã phân tích trung gian từ thử nghiệm SELECT https://news.medxy.ai/unraveling-the-cardiovascular-benefits-of-semaglutide-insights-from-the-select-trial-mediation-analysis/Medxy AIen2026-09-28T05:50:34-07:00Unraveling the Cardiovascular Benefits of Semaglutide: Insights from the SELECT Trial Mediation Analysis https://news.medxy.ai/zh/78742-2/Medxy AIzh2026-09-28T05:35:30-07:00EYS相关视网膜变性：遗传多样性、临床表现及疾病进展 https://news.medxy.ai/ja/eys-retinal-degeneration-korea/Medxy AIja2026-09-28T05:35:12-07:00韓国におけるEYS関連網膜変性：遺伝的多様性、臨床像、疾患進行の新知見 https://news.medxy.ai/vi/eys-retinopathy-korea/Medxy AIvi2026-09-28T05:34:50-07:00Thoái hóa võng mạc liên quan đến EYS ở Hàn Quốc: biến thiên di truyền, đặc điểm lâm sàng và tiến triển bệnh https://news.medxy.ai/eys-associated-retinal-degeneration-in-south-korea-insights-into-genetic-variability-clinical-features-and-disease-progression/Medxy AIen2026-09-28T05:34:31-07:00EYS-Associated Retinal Degeneration in South Korea: Insights into Genetic Variability, Clinical Features, and Disease Progression https://news.medxy.ai/zh/parathyroid-identification/Medxy AIzh2026-09-28T05:33:54-07:00甲状腺切除术中甲状旁腺肉眼识别的临床价值：基于决策曲线分析的研究洞见 https://news.medxy.ai/ja/78736-2/Medxy AIja2026-09-28T05:33:35-07:00甲状腺切除術中における副甲状腺の肉眼的同定 https://news.medxy.ai/vi/parathyroid-identification-2/Medxy AIvi2026-09-28T05:33:15-07:00Đánh giá nhận diện tuyến cận giáp bằng mắt thường trong phẫu thuật cắt tuyến giáp: góc nhìn từ phân tích đường cong quyết định https://news.medxy.ai/evaluating-visual-parathyroid-identification-during-thyroidectomy-insights-from-decision-curve-analysis/Medxy AIen2026-09-28T05:32:56-07:00Evaluating Visual Parathyroid Identification During Thyroidectomy: Insights from Decision Curve Analysis https://news.medxy.ai/zh/parathyroidectomy-bisphosphonates-bone-density/Medxy AIzh2026-09-28T05:32:18-07:00甲状旁腺切除术与双膦酸盐治疗对骨密度影响的评估：来自多机构研究的启示 https://news.medxy.ai/ja/parathyroid-surgery-bisphosphonate/Medxy AIja2026-09-28T05:31:58-07:00副甲状腺摘出術とビスホスホネート療法は骨密度をどこまで改善するか：多施設研究からの知見 https://news.medxy.ai/vi/parathyroid-bisphosphonates-bone-density/Medxy AIvi2026-09-28T05:31:37-07:00Cắt tuyến cận giáp và bisphosphonates ảnh hưởng thế nào đến mật độ xương? Kết quả từ một nghiên cứu đa cơ sở https://news.medxy.ai/evaluating-the-impact-of-parathyroidectomy-and-bisphosphonate-therapy-on-bone-mineral-density-insights-from-a-multi-institutional-study/Medxy AIen2026-09-28T05:31:17-07:00Evaluating the Impact of Parathyroidectomy and Bisphosphonate Therapy on Bone Mineral Density: Insights from a Multi-Institutional Study https://news.medxy.ai/zh/tubo-ovarian-abscess/Medxy AIzh2026-09-28T05:30:39-07:00输卵管卵巢脓肿治疗新证据：经阴道引流与腹腔镜的多中心随机试验对比 https://news.medxy.ai/ja/tubo-ovarian-abscess-2/Medxy AIja2026-09-28T05:30:21-07:00卵管卵巣膿瘍に対する経腟ドレナージと腹腔鏡手術の比較：多施設ランダム化試験からの知見 https://news.medxy.ai/vi/vaginal-drainage-vs-laparoscopy/Medxy AIvi2026-09-28T05:30:03-07:00Dẫn lưu qua đường âm đạo hay nội soi ổ bụng trong áp-xe vòi trứng-buồng trứng? Kết quả từ một thử nghiệm ngẫu nhiên đa trung tâm https://news.medxy.ai/assessing-transvaginal-drainage-versus-laparoscopy-for-tubo-ovarian-abscess-insights-from-a-multicenter-randomized-trial/Medxy AIen2026-09-28T05:29:46-07:00Assessing Transvaginal Drainage Versus Laparoscopy for Tubo-Ovarian Abscess: Insights from a Multicenter Randomized Trial https://news.medxy.ai/zh/advanced-ovarian-cancer-trial/Medxy AIzh2026-09-28T05:29:11-07:00晚期上皮性卵巢癌中卡铂、紫杉醇与帕博利珠单抗联合HIPEC及奥拉帕利维持治疗的创新性Ⅱ期试验 https://news.medxy.ai/ja/ovarian-cancer-trial/Medxy AIja2026-09-28T05:28:52-07:00進行上皮性卵巣癌に対する carboplatin/paclitaxel と pembrolizumab、HIPEC および olaparib 維持療法を組み合わせた革新的第II相試験 https://news.medxy.ai/vi/advanced-phase-ii-carboplatin-paclitaxel-pembrolizumab-ovarian-cancer/Medxy AIvi2026-09-28T05:28:33-07:00Thử nghiệm pha II tiên tiến về carboplatin, paclitaxel và pembrolizumab kết hợp HIPEC cùng duy trì olaparib trong ung thư biểu mô buồng trứng tiến triển https://news.medxy.ai/innovative-phase-ii-trial-of-carboplatin-paclitaxel-and-pembrolizumab-with-hipec-and-olaparib-maintenance-in-advanced-epithelial-ovarian-cancer/Medxy AIen2026-09-28T05:28:14-07:00Innovative Phase II Trial of Carboplatin, Paclitaxel, and Pembrolizumab with HIPEC and Olaparib Maintenance in Advanced Epithelial Ovarian Cancer https://news.medxy.ai/zh/predicting-first-nations-births/Medxy AIzh2026-09-28T05:27:37-07:00预测 First Nations 妇女足月分娩：来自昆士兰队列研究的启示 https://news.medxy.ai/ja/first-nations-delivery/Medxy AIja2026-09-28T05:27:21-07:00First Nations女性の正期産を予測する：クイーンズランド・コホート研究からの知見 https://news.medxy.ai/vi/full-term-birth-forecast/Medxy AIvi2026-09-28T05:27:02-07:00Dự báo sinh đủ tháng ở phụ nữ First Nations: Phát hiện từ một nghiên cứu đoàn hệ tại Queensland https://news.medxy.ai/predicting-term-birth-among-first-nations-women-insights-from-a-queensland-cohort-study/Medxy AIen2026-09-28T05:26:45-07:00Predicting Term Birth Among First Nations Women: Insights from a Queensland Cohort Study https://news.medxy.ai/zh/78712-2/Medxy AIzh2026-09-28T05:26:10-07:00丁酰胆碱酯酶：肝纤维化潜在能靶点 https://news.medxy.ai/ja/78711-2/Medxy AIja2026-09-28T05:25:52-07:00肝線維化におけるブチリルコリンエステラーゼの役割：肝疾患における新たなコリン作動性標的 https://news.medxy.ai/vi/butyrylcholinesterase-liver-fibrosis/Medxy AIvi2026-09-28T05:25:33-07:00Vai trò của Butyrylcholinesterase trong xơ hóa gan: một mục tiêu cholinergic mới trong bệnh gan https://news.medxy.ai/unveiling-the-role-of-butyrylcholinesterase-in-hepatic-fibrosis-a-novel-cholinergic-target-in-liver-disease/Medxy AIen2026-09-28T05:25:12-07:00Unveiling the Role of Butyrylcholinesterase in Hepatic Fibrosis: A Novel Cholinergic Target in Liver Disease https://news.medxy.ai/zh/young-adult-stroke-rise/Medxy AIzh2026-09-28T05:24:36-07:00年轻成人卒中发病上升：来自人群研究的危险因素演变与死亡趋势 https://news.medxy.ai/ja/stroke-increase-young-adults/Medxy AIja2026-09-28T05:24:20-07:00若年成人で脳卒中が増加：人口ベース研究が示す危険因子の変化と死亡率の推移 https://news.medxy.ai/vi/stroke-increase-young/Medxy AIvi2026-09-28T05:23:58-07:00Đột quỵ gia tăng ở người trẻ: thay đổi hồ sơ nguy cơ và xu hướng tử vong từ một nghiên cứu dựa trên quần thể https://news.medxy.ai/rising-stroke-incidence-in-young-adults-evolving-risk-profiles-and-mortality-trends-from-a-population-based-study/Medxy AIen2026-09-28T05:23:37-07:00Rising Stroke Incidence in Young Adults: Evolving Risk Profiles and Mortality Trends from a Population-Based Study https://news.medxy.ai/zh/multidimensional-decline/Medxy AIzh2026-09-28T05:23:03-07:00多维功能衰退早于心血管事件：ASPREE 研究新启示 https://news.medxy.ai/ja/functional-decline-cardiovascular-events/Medxy AIja2026-09-28T05:22:45-07:00機能低下は心血管イベントに先行する：ASPREE研究が示す新知見 https://news.medxy.ai/vi/multidimensional-function-decline/Medxy AIvi2026-09-28T05:22:26-07:00Suy giảm chức năng đa chiều báo trước biến cố tim mạch: Góc nhìn từ nghiên cứu ASPREE https://news.medxy.ai/multidimensional-functional-decline-precedes-cardiovascular-events-insights-from-the-aspree-study/Medxy AIen2026-09-28T05:22:08-07:00Multidimensional Functional Decline Precedes Cardiovascular Events: Insights from the ASPREE Study https://news.medxy.ai/zh/af-density-stroke-risk/Medxy AIzh2026-09-28T05:21:32-07:00心房颤动密度：一种提升缺血性卒中风险预测的新型生物标志物 https://news.medxy.ai/ja/afib-density-stroke-risk/Medxy AIja2026-09-28T05:21:12-07:00心房細動密度：虚血性脳卒中リスク予測を高める新たなバイオマーカー https://news.medxy.ai/vi/afib-density-biomarker/Medxy AIvi2026-09-28T05:20:49-07:00Mật độ rung nhĩ: biomarker mới giúp dự báo chính xác hơn nguy cơ đột quỵ thiếu máu cục bộ https://news.medxy.ai/atrial-fibrillation-density-a-novel-biomarker-enhancing-ischaemic-stroke-risk-prediction/Medxy AIen2026-09-28T05:20:29-07:00Atrial Fibrillation Density: A Novel Biomarker Enhancing Ischaemic Stroke Risk Prediction https://news.medxy.ai/zh/venous-integrity/Medxy AIzh2026-09-28T02:09:59-07:00静脉完整性：预测乳头保留乳腺切除术后乳头-乳晕复合体坏死的关键指标 https://news.medxy.ai/ja/venous-integrity-nac-necrosis/Medxy AIja2026-09-28T02:09:35-07:00乳頭温存乳房切除術後NAC壊死の鍵となる予測因子としての静脈の完全性 https://news.medxy.ai/vi/vein-integrity-predictor/Medxy AIvi2026-09-28T02:09:13-07:00Tính toàn vẹn tĩnh mạch: yếu tố dự báo then chốt của hoại tử phức hợp quầng-vú sau phẫu thuật cắt tuyến vú bảo tồn núm vú https://news.medxy.ai/venous-integrity-as-a-key-predictor-of-nipple-areolar-complex-necrosis-following-nipple-sparing-mastectomy/Medxy AIen2026-09-28T02:08:53-07:00Venous Integrity as a Key Predictor of Nipple-Areolar Complex Necrosis Following Nipple-Sparing Mastectomy https://news.medxy.ai/venous-drainage-integrity-as-a-crucial-factor-in-preventing-nipple-areolar-complex-necrosis-post-nipple-sparing-mastectomy-insights-from-cadaveric-and-clinical-studies/Medxy AIen2026-09-27T07:41:09-07:00Venous Drainage Integrity as a Crucial Factor in Preventing Nipple-Areolar Complex Necrosis Post Nipple-Sparing Mastectomy: Insights from Cadaveric and Clinical Studies https://news.medxy.ai/zh/radix-high-spreader-graft/Medxy AIzh2026-09-27T07:40:33-07:00Radix High Spreader Graft：以精准与稳定推动鼻背框架重建 https://news.medxy.ai/ja/radix-nose-reconstruction/Medxy AIja2026-09-27T07:40:15-07:00Radix High Spreader Graft法：精密性と安定性で切り拓く鼻背再建 https://news.medxy.ai/vi/high-precision-nose-graft/Medxy AIvi2026-09-27T07:39:55-07:00Radix High Spreader Graft: Nâng cao tái tạo khung mũi sống lưng với độ chính xác và vững chắc https://news.medxy.ai/radix-high-spreader-grafts-advancing-dorsal-nasal-framework-reconstruction-with-precision-and-stability/Medxy AIen2026-09-27T07:39:37-07:00Radix High Spreader Grafts: Advancing Dorsal Nasal Framework Reconstruction with Precision and Stability https://news.medxy.ai/zh/icu-treatment-appropriateness/Medxy AIzh2026-09-27T07:38:59-07:00ICU治疗是否“太过”或“不合适”？荷兰全国研究揭示其发生率、相关因素及对患者结局的影响 https://news.medxy.ai/ja/78228-2/Medxy AIja2026-09-27T07:38:42-07:00ICU治療は「過剰」あるいは「不適切」か？オランダの全国調査が明らかにする発生率、関連因子、および患者の転帰への影響 https://news.medxy.ai/vi/icu-treatment-mismatch/Medxy AIvi2026-09-27T07:38:21-07:00Cảm nhận về sự không phù hợp trong điều trị hồi sức tích cực: Tỷ lệ hiện mắc, yếu tố dự báo và ảnh hưởng đến kết cục người bệnh tại các ICU ở Hà Lan https://news.medxy.ai/perceived-inappropriateness-of-intensive-care-treatment-prevalence-predictors-and-impact-on-patient-outcomes-in-dutch-icus/Medxy AIen2026-09-27T07:38:01-07:00Perceived Inappropriateness of Intensive Care Treatment: Prevalence, Predictors, and Impact on Patient Outcomes in Dutch ICUs https://news.medxy.ai/zh/communication-skills-osce/Medxy AIzh2026-09-27T07:37:23-07:00“完成良好”并不等于同样出色：内科住院医师虚拟与线下OSCE沟通技能评估差异解析 https://news.medxy.ai/ja/virtual-vs-in-person-osce/Medxy AIja2026-09-27T07:37:05-07:00仮想OSCEと対面OSCEで「十分実施」の意味は同じか：研修医のコミュニケーション評価を読み解く https://news.medxy.ai/vi/78220-2/Medxy AIvi2026-09-27T07:36:47-07:00Phân tích sự khác biệt trong đánh giá kỹ năng giao tiếp giữa kỳ thi OSCE trực tuyến và trực tiếp đối với bác sĩ nội trú chuyên ngành Nội khoa https://news.medxy.ai/when-well-done-is-not-the-same-dissecting-communication-skill-assessment-in-virtual-versus-in-person-osces-among-medicine-residents/Medxy AIen2026-09-27T07:36:28-07:00When Well-Done Is Not the Same: Dissecting Communication Skill Assessment in Virtual versus In-Person OSCEs Among Medicine Residents https://news.medxy.ai/zh/idh3-aml-resistance/Medxy AIzh2026-09-27T07:35:45-07:00IDH3：调控AML干细胞维奈克拉耐药的代谢检查点 https://news.medxy.ai/ja/78211-2/Medxy AIja2026-09-27T07:35:27-07:00IDH3：AML幹細胞におけるベネトクラクス耐性を制御する代謝チェックポイント https://news.medxy.ai/vi/idh3-metabolism-aml/Medxy AIvi2026-09-27T07:35:08-07:00IDH3: Điểm kiểm soát chuyển hóa chi phối kháng venetoclax ở tế bào gốc AML https://news.medxy.ai/idh3-as-a-metabolic-checkpoint-modulating-venetoclax-resistance-in-aml-stem-cells/Medxy AIen2026-09-27T07:34:49-07:00IDH3 as a Metabolic Checkpoint Modulating Venetoclax Resistance in AML Stem Cells https://news.medxy.ai/zh/copd-diabetes-bone-risk/Medxy AIzh2026-09-27T07:34:06-07:00COPD与2型糖尿病：全国倾向评分匹配队列中的骨骼风险比较 https://news.medxy.ai/ja/copd-vs-diabetes-bone-risk/Medxy AIja2026-09-27T07:33:43-07:00COPDと2型糖尿病はどちらが骨に厳しいのか：全国規模傾向スコアマッチ・コホート研究が示す比較リスク https://news.medxy.ai/vi/copd-diabetes-bone-risk-2/Medxy AIvi2026-09-27T07:33:25-07:00COPD hay đái tháo đường týp 2: bệnh nào gây nguy cơ xương lớn hơn? Bằng chứng từ một đoàn hệ toàn quốc ghép điểm xu hướng https://news.medxy.ai/comparative-skeletal-risks-of-copd-and-type-2-diabetes-mellitus-insights-from-a-nationwide-propensity-matched-cohort/Medxy AIen2026-09-27T07:33:06-07:00Comparative Skeletal Risks of COPD and Type 2 Diabetes Mellitus: Insights from a Nationwide Propensity-Matched Cohort https://news.medxy.ai/zh/covid19-pediatric-otitis/Medxy AIzh2026-09-27T07:32:28-07:00COVID-19对儿科分泌性中耳炎手术的影响：来自日本时间序列研究的启示 https://news.medxy.ai/ja/covid19-pediatric-ear-surgery/Medxy AIja2026-09-27T07:32:10-07:00COVID-19が小児滲出性中耳炎手術に与えた影響――日本の時系列研究から見えたもの https://news.medxy.ai/vi/covid19-ear-surgery-impact/Medxy AIvi2026-09-27T07:31:52-07:00Đại dịch COVID-19 tác động thế nào đến phẫu thuật viêm tai giữa thanh dịch ở trẻ em? Dữ liệu từ nghiên cứu chuỗi thời gian tại Nhật Bản https://news.medxy.ai/impact-of-covid-19-on-pediatric-otitis-media-with-effusion-surgery-insights-from-a-japanese-time-series-study/Medxy AIen2026-09-27T07:31:34-07:00Impact of COVID-19 on Pediatric Otitis Media With Effusion Surgery: Insights from a Japanese Time-Series Study https://news.medxy.ai/zh/78192-2/Medxy AIzh2026-09-27T07:30:54-07:00外阴癌的现代外科治疗：平衡生存率提升与再次手术率增加——一项芬兰全国性研究的启示 https://news.medxy.ai/ja/78191-2/Medxy AIja2026-09-27T07:30:34-07:00外陰がんの現代的な外科的治療：生存率の向上と再手術率の上昇とのバランス — フィンランドの全国規模研究からの知見 https://news.medxy.ai/vi/78190-2/Medxy AIvi2026-09-27T07:30:12-07:00Quản lý phẫu thuật hiện đại đối với ung thư âm hộ: Cân bằng giữa việc cải thiện tỷ lệ sống còn và gia tăng tỷ lệ phẫu thuật lại — Những hiểu biết từ một nghiên cứu quy mô toàn quốc tại Phần Lan https://news.medxy.ai/vulvar-cancer-surgery/Medxy AIen2026-09-27T07:29:52-07:00Contemporary Surgical Management of Vulvar Cancer: Balancing Improved Survival with Increased Reoperation Rates — Insights from a Finnish Nationwide Study https://news.medxy.ai/zh/primary-aldosterone-syndrome/Medxy AIzh2026-09-27T07:29:07-07:00原发性醛固酮增多症诊断中连续醛固酮-肾素比值解读的优化策略 https://news.medxy.ai/ja/optimize-aldo-renin-ratio/Medxy AIja2026-09-27T07:28:51-07:00原発性アルドステロン症診断における連続アルドステロン・レニン比の解釈を最適化する https://news.medxy.ai/vi/aldosterone-renin-ratio/Medxy AIvi2026-09-27T07:28:28-07:00Tối ưu hóa diễn giải hai lần đo tỷ lệ aldosterone trên renin trong chẩn đoán cường aldosterone nguyên phát https://news.medxy.ai/optimizing-interpretation-of-serial-aldosterone-to-renin-ratio-measurements-in-primary-aldosteronism-diagnosis/Medxy AIen2026-09-27T07:28:10-07:00Optimizing Interpretation of Serial Aldosterone-to-Renin Ratio Measurements in Primary Aldosteronism Diagnosis https://news.medxy.ai/zh/78182-2/Medxy AIzh2026-09-27T07:27:14-07:00房颤消融术后的卒中与体循环栓塞：来自 EMBOL-AF 全球注册研究及当代循证医学证据的启示 https://news.medxy.ai/ja/78181-2/Medxy AIja2026-09-27T07:26:53-07:00心房細動アブレーション後の脳卒中および全身性塞栓症：EMBOL-AFグローバルレジストリおよび最新のエビデンスからの知見 https://news.medxy.ai/vi/78180-2/Medxy AIvi2026-09-27T07:26:24-07:00Đột quỵ và thuyên tắc hệ thống sau thủ thuật triệt đốt rung nhĩ: Những hiểu biết từ cơ sở dữ liệu toàn cầu EMBOL-AF và các bằng chứng hiện đại https://news.medxy.ai/stroke-and-systemic-embolism-following-atrial-fibrillation-ablation-insights-from-the-embol-af-global-registry-and-contemporary-evidence/Medxy AIen2026-09-27T07:26:01-07:00Stroke and Systemic Embolism Following Atrial Fibrillation Ablation: Insights from the EMBOL-AF Global Registry and Contemporary Evidence https://news.medxy.ai/zh/non-contrast-mra/Medxy AIzh2026-09-27T07:19:15-07:00无对比剂磁共振血管成像：DIEP皮瓣术前规划中替代增强CT的安全高效方案 https://news.medxy.ai/ja/78014-2/Medxy AIja2026-09-27T07:18:55-07:00造影剤を用いないMRA：DIEP皮弁術の術前計画において造影CTに代わる安全かつ効率的な手法 https://news.medxy.ai/vi/78012-2/Medxy AIvi2026-09-27T07:18:35-07:00Chụp mạch cộng hưởng từ không dùng thuốc đối quang có thể thay thế chụp cắt lớp vi tính (CT) có tiêm thuốc đối quang trong lập kế hoạch phẫu thuật vạt DIEP https://news.medxy.ai/noncontrast-magnetic-resonance-angiography-as-a-noninferior-and-safer-alternative-to-contrast-enhanced-ct-in-diep-flap-planning-insights-from-a-4-year-cohort-study/Medxy AIen2026-09-27T07:18:15-07:00Noncontrast Magnetic Resonance Angiography as a Noninferior and Safer Alternative to Contrast-Enhanced CT in DIEP Flap Planning: Insights from a 4-Year Cohort Study https://news.medxy.ai/zh/dupuytren-treatment-comparison/Medxy AIzh2026-09-27T07:17:29-07:00复发性Dupuytren挛缩：手术筋膜切除术与胶原酶注射的最佳管理比较 https://news.medxy.ai/ja/dupuytren-contracture-treatment/Medxy AIja2026-09-27T07:17:09-07:00再発性デュピュイトラン拘縮：最適治療を探る外科的筋膜切除術とコラゲナーゼ注射の比較 https://news.medxy.ai/vi/dupuytren-treatment-comparison-2/Medxy AIvi2026-09-27T07:16:45-07:00Co rút Dupuytren tái phát: So sánh phẫu thuật cắt cân gan tay và tiêm collagenase để tối ưu hóa điều trị https://news.medxy.ai/recurrent-dupuytren-contracture-comparing-surgical-fasciectomy-and-collagenase-injection-for-optimal-management/Medxy AIen2026-09-27T07:16:27-07:00Recurrent Dupuytren Contracture: Comparing Surgical Fasciectomy and Collagenase Injection for Optimal Management https://news.medxy.ai/zh/breast-reconstruction-outcomes/Medxy AIzh2026-09-27T07:15:46-07:00放疗后乳房重建：胸肌前位与胸肌后位植入物的长期结局前瞻性比较 https://news.medxy.ai/ja/77993-2/Medxy AIja2026-09-27T07:15:26-07:00放射線療法後の乳房再建：胸筋前および胸筋後へのインプラント留置における長期成績の比較（前向き研究） https://news.medxy.ai/vi/breast-reconstruction-after-radiation/Medxy AIvi2026-09-27T07:15:03-07:00Tái tạo vú trước cơ hay dưới cơ sau xạ trị: Phân tích tiến cứu về kết cục dài hạn https://news.medxy.ai/prepectoral-vs-subpectoral-breast-reconstruction-after-radiotherapy-a-prospective-long-term-outcome-analysis/Medxy AIen2026-09-27T07:14:45-07:00Prepectoral vs. Subpectoral Breast Reconstruction After Radiotherapy: A Prospective Long-Term Outcome Analysis https://news.medxy.ai/zh/ai-nose-surgery-detection/Medxy AIzh2026-09-27T07:13:58-07:00AI 识别线上鼻整形术照片中的数字篡改：推动手术透明化的新方向 https://news.medxy.ai/ja/ai-rhinoplasty-detection/Medxy AIja2026-09-27T07:13:37-07:00AIがオンライン鼻形成術写真の改変を検出：外科的透明性を高める新たな展開 https://news.medxy.ai/vi/ai-nose-job-detection/Medxy AIvi2026-09-27T07:13:18-07:00AI phát hiện ảnh nâng mũi trực tuyến bị chỉnh sửa kỹ thuật số: Bước tiến mới trong minh bạch phẫu thuật https://news.medxy.ai/ai-detects-digital-manipulation-in-online-rhinoplasty-photos-a-new-frontier-for-surgical-transparency/Medxy AIen2026-09-27T07:12:59-07:00AI Detects Digital Manipulation in Online Rhinoplasty Photos: A New Frontier for Surgical Transparency https://news.medxy.ai/zh/nmdar-brain-structure/Medxy AIzh2026-09-27T07:12:17-07:00NMDAR脑炎的脑结构改变与长期预后：德国横断面研究带来的新认识 https://news.medxy.ai/ja/nmda-encephalitis-brain-structure/Medxy AIja2026-09-27T07:11:57-07:00NMDA受容体脳炎の脳構造変化と長期転帰：ドイツ横断研究が示す新知見 https://news.medxy.ai/vi/nmda-encephalitis-brain-structure-2/Medxy AIvi2026-09-27T07:11:34-07:00Thay đổi cấu trúc não và kết cục dài hạn ở viêm não thụ thể NMDA: Góc nhìn từ một nghiên cứu cắt ngang tại Đức https://news.medxy.ai/structural-brain-changes-and-long-term-outcomes-in-nmda-receptor-encephalitis-insights-from-a-german-cross-sectional-study/Medxy AIen2026-09-27T07:11:15-07:00Structural Brain Changes and Long-Term Outcomes in NMDA Receptor Encephalitis: Insights from a German Cross-Sectional Study https://news.medxy.ai/zh/continuous-ketamine-infusion/Medxy AIzh2026-09-27T07:10:33-07:00连续静脉氯胺酮输注为难治性双相抑郁带来新希望：一项突破性随机试验 https://news.medxy.ai/ja/77972-2/Medxy AIja2026-09-27T07:10:17-07:00ケタミンの持続静脈内投与が難治性双極性うつ病に新たな希望をもたらす：画期的な無作為化試験 https://news.medxy.ai/vi/ketamine-bipolar-depression/Medxy AIvi2026-09-27T07:09:56-07:00Ketamine truyền nhiều đợt cho thấy triển vọng trong điều trị trầm cảm lưỡng cực kháng trị: kết quả từ một thử nghiệm ngẫu nhiên đột phá https://news.medxy.ai/serial-ketamine-infusions-show-promise-in-treatment-resistant-bipolar-depression-a-groundbreaking-randomized-trial/Medxy AIen2026-09-27T07:09:36-07:00Serial Ketamine Infusions Show Promise in Treatment-Resistant Bipolar Depression: A Groundbreaking Randomized Trial https://news.medxy.ai/zh/ace-in-early-psychosis/Medxy AIzh2026-09-27T07:08:52-07:00早期精神病中的血管紧张素转换酶：潜在生物标志物与治疗靶点 https://news.medxy.ai/ja/early-psychosis-biomarkers/Medxy AIja2026-09-27T07:08:36-07:00早期精神病におけるバイオマーカーと治療標的としてのアンジオテンシン変換酵素 https://news.medxy.ai/vi/ace-biomarker-target/Medxy AIvi2026-09-27T07:08:19-07:00ACE: Dấu ấn sinh học và đích điều trị tiềm năng trong rối loạn loạn thần giai đoạn sớm https://news.medxy.ai/angiotensin-converting-enzyme-as-a-biomarker-and-therapeutic-target-in-early-stage-psychosis/Medxy AIen2026-09-27T07:08:02-07:00Angiotensin-Converting Enzyme as a Biomarker and Therapeutic Target in Early-Stage Psychosis https://news.medxy.ai/zh/parental-similarity-mental-disorders/Medxy AIzh2026-09-27T07:07:24-07:00揭示择偶同类配对：父母相似性如何影响精神障碍的遗传率与人群患病率 https://news.medxy.ai/ja/selective-breeding-mental-illness/Medxy AIja2026-09-27T07:07:06-07:00精神疾患の選択的交配を読み解く：親の類似性が疾患の遺伝率と人口有病率をどう左右するか https://news.medxy.ai/vi/selective-mating-genetics/Medxy AIvi2026-09-27T07:06:48-07:00Giải mã giao phối chọn lọc: Tính tương đồng giữa cha mẹ định hình tính di truyền và tỷ lệ hiện mắc rối loạn tâm thần ở cấp độ quần thể https://news.medxy.ai/unraveling-assortative-mating-how-parental-similarity-shapes-psychiatric-disorder-heritability-and-prevalence-at-the-population-level/Medxy AIen2026-09-27T07:06:31-07:00Unraveling Assortative Mating: How Parental Similarity Shapes Psychiatric Disorder Heritability and Prevalence at the Population Level https://news.medxy.ai/zh/chatgpt4o-icu-review/Medxy AIzh2026-09-27T07:05:53-07:00重症医学专科复习题中的 ChatGPT-4o：准确率高，但多模态解读存在风险 https://news.medxy.ai/ja/chatgpt4o-icu-evaluation/Medxy AIja2026-09-27T07:05:35-07:00集中治療ボード試験でのChatGPT-4o評価：高精度だがマルチモーダル解釈に課題 https://news.medxy.ai/vi/77941-2/Medxy AIvi2026-09-27T07:05:16-07:00ChatGPT-4o trong các câu hỏi ôn tập chuyên ngành Y học Hồi sức tích cực: Độ chính xác cao nhưng tiềm ẩn rủi ro trong việc diễn giải đa phương thức https://news.medxy.ai/evaluating-chatgpt-4o-in-critical-care-board-review-high-accuracy-but-risky-multimodal-interpretations/Medxy AIen2026-09-27T07:04:58-07:00Evaluating ChatGPT-4o in Critical Care Board Review: High Accuracy but Risky Multimodal Interpretations https://news.medxy.ai/zh/esophageal-ultrasound-shock/Medxy AIzh2026-09-27T07:04:20-07:00经食管肺部超声联合复苏性经食管超声心动图：休克评估的新进展与临床可行性 https://news.medxy.ai/ja/shock-assessment-enhancement/Medxy AIja2026-09-27T07:04:01-07:00ショック評価をさらに高精度に：蘇生TEE併用経食道肺超音波の実現可能性と臨床的意義 https://news.medxy.ai/vi/lung-ultrasound-feasibility/Medxy AIvi2026-09-27T07:03:36-07:00Nâng cao đánh giá sốc: tính khả thi và tác động của siêu âm phổi qua thực quản kết hợp với siêu âm tim qua thực quản hồi sức https://news.medxy.ai/enhancing-shock-evaluation-feasibility-and-impact-of-transesophageal-lung-ultrasound-combined-with-resuscitative-transesophageal-echocardiography/Medxy AIen2026-09-27T07:03:19-07:00Enhancing Shock Evaluation: Feasibility and Impact of Transesophageal Lung Ultrasound Combined with Resuscitative Transesophageal Echocardiography https://news.medxy.ai/zh/pediatric-sepsis-care/Medxy AIzh2026-09-27T07:02:31-07:00揭示儿童脓毒症住院前医疗接触：早期识别与干预的新机会 https://news.medxy.ai/ja/pediatric-sepsis-early-care/Medxy AIja2026-09-27T07:02:11-07:00小児敗血症の入院前医療受診に着目する：早期発見・介入の機会 https://news.medxy.ai/vi/pediatric-sepsis-care-2/Medxy AIvi2026-09-27T07:01:52-07:00Nhận diện các lần tiếp xúc y tế trước nhập viện ở nhiễm trùng huyết nhi khoa: Cơ hội phát hiện sớm và can thiệp kịp thời https://news.medxy.ai/unveiling-pre-hospitalization-healthcare-encounters-in-pediatric-sepsis-opportunities-for-early-detection-and-intervention/Medxy AIen2026-09-27T07:01:33-07:00Unveiling Pre-Hospitalization Healthcare Encounters in Pediatric Sepsis: Opportunities for Early Detection and Intervention https://news.medxy.ai/zh/nt-probnp-interpretation/Medxy AIzh2026-09-27T06:00:51-07:00住院成人极高 NT-proBNP 的临床解读：不止于心力衰竭 https://news.medxy.ai/ja/nt-probnp-complexity/Medxy AIja2026-09-27T06:00:34-07:00入院患者の超高値NT-proBNPを読み解く：心不全だけではない臨床的複雑性 https://news.medxy.ai/vi/nt-probnp-high/Medxy AIvi2026-09-27T06:00:14-07:00NT-proBNP tăng cực cao ở bệnh nhân nhập viện: không chỉ là suy tim https://news.medxy.ai/unraveling-the-clinical-complexity-of-extremely-high-nt-probnp-in-hospitalized-adults-beyond-heart-failure/Medxy AIen2026-09-27T05:59:54-07:00Unraveling the Clinical Complexity of Extremely High NT-proBNP in Hospitalized Adults: Beyond Heart Failure https://news.medxy.ai/zh/ai-home-care-insights/Medxy AIzh2026-09-26T06:59:14-07:00洞察家庭护理中的 AI：关键利益相关方的观点与证据综述 https://news.medxy.ai/ja/ai-home-care-stakeholders/Medxy AIja2026-09-26T06:58:57-07:00在宅ケアにおけるAI活用をめぐる主要ステークホルダーの視点：エビデンスに基づく総説 https://news.medxy.ai/vi/ai-home-care-overview/Medxy AIvi2026-09-26T06:58:38-07:00Góc nhìn của các bên liên quan về trí tuệ nhân tạo trong công việc chăm sóc tại nhà: Tổng quan dựa trên bằng chứng https://news.medxy.ai/understanding-key-stakeholders-perspectives-towards-artificial-intelligence-in-home-care-work-an-evidence-based-review/Medxy AIen2026-09-26T06:58:17-07:00Understanding Key Stakeholders’ Perspectives Towards Artificial Intelligence in Home Care Work: An Evidence-Based Review https://news.medxy.ai/zh/medical-communication-evolution/Medxy AIzh2026-09-26T06:57:30-07:00从入门到精通：内科医生医疗目标沟通能力的演进——一项跨培训阶段质性研究 https://news.medxy.ai/ja/goals-of-care-dialogue/Medxy AIja2026-09-26T06:57:12-07:00内科医におけるGoals-of-Care対話能力の発達：研修段階を通じた質的研究からの示唆 https://news.medxy.ai/vi/care-goal-discussion/Medxy AIvi2026-09-26T06:56:51-07:00Năng lực thảo luận về mục tiêu chăm sóc ở bác sĩ nội khoa: Góc nhìn từ một nghiên cứu định tính theo các giai đoạn đào tạo https://news.medxy.ai/evolving-competence-in-goals-of-care-discussions-among-internal-medicine-physicians-insights-from-a-qualitative-study-across-training-levels/Medxy AIen2026-09-26T06:56:33-07:00Evolving Competence in Goals-of-Care Discussions Among Internal Medicine Physicians: Insights from a Qualitative Study Across Training Levels https://news.medxy.ai/ja/tobacco-use-treatment/Medxy AIja2026-09-26T06:55:52-07:00タバコ使用治療：2026年VA/DoD臨床実践ガイドラインの要点 https://news.medxy.ai/vi/smoking-dependence-treatment/Medxy AIvi2026-09-26T06:55:19-07:00Điều trị lệ thuộc thuốc lá: Những điểm chính từ Hướng dẫn lâm sàng VA/DoD 2026 https://news.medxy.ai/zh/tobacco-use-treatment-2/Medxy AIzh2026-09-26T06:54:48-07:00烟草使用治疗：2026 年 VA/DoD 临床实践指南要点 https://news.medxy.ai/tobacco-use-treatment-key-points-from-the-2026-va-dod-clinical-practice-guideline/Medxy AIen2026-09-26T06:54:21-07:00Tobacco Use Treatment: Key Points from the 2026 VA/DoD Clinical Practice Guideline https://news.medxy.ai/zh/b-cell-lymphoma/Medxy AIzh2026-09-26T06:53:08-07:00解码大B细胞淋巴瘤异质性：单细胞图谱揭示与患者结局相关的恶性细胞原型 https://news.medxy.ai/ja/b-cell-lymphoma-2/Medxy AIja2026-09-26T06:52:50-07:00大B細胞リンパ腫の異質性を解読する：単一細胞アトラスが患者転帰に関連する悪性アーキタイプを同定 https://news.medxy.ai/vi/b-cell-lymphoma-heterogeneity/Medxy AIvi2026-09-26T06:52:28-07:00Giải mã tính dị hợp của u lympho tế bào B lớn: Bản đồ đơn bào xác định các kiểu hình ác tính liên quan đến kết cục người bệnh https://news.medxy.ai/decoding-large-b-cell-lymphoma-heterogeneity-a-single-cell-atlas-identifies-malignant-archetypes-linked-to-patient-outcomes/Medxy AIen2026-09-26T06:52:08-07:00Decoding Large B Cell Lymphoma Heterogeneity: A Single-Cell Atlas Identifies Malignant Archetypes Linked to Patient Outcomes https://news.medxy.ai/zh/aml-transplant-optimization/Medxy AIzh2026-09-26T06:51:05-07:00借助微小残留病检测优化成人急性髓系白血病的异基因造血细胞移植 https://news.medxy.ai/ja/mrd-testing-adult-aml/Medxy AIja2026-09-26T06:50:47-07:00MRD検査で成人AMLの同種造血細胞移植を個別化する https://news.medxy.ai/vi/blood-stem-cell-transplant/Medxy AIvi2026-09-26T06:50:26-07:00Cá thể hóa ghép tế bào tạo máu đồng loài ở người lớn mắc AML bằng xét nghiệm MRD https://news.medxy.ai/personalizing-allogeneic-hematopoietic-cell-transplantation-in-adult-aml-using-measurable-residual-disease-testing/Medxy AIen2026-09-26T06:50:05-07:00Personalizing Allogeneic Hematopoietic Cell Transplantation in Adult AML Using Measurable Residual Disease Testing https://news.medxy.ai/zh/soluble-bcma/Medxy AIzh2026-09-26T06:49:20-07:00可溶性 BCMA：界定新诊断多发性骨髓瘤肿瘤表型与预后的关键生物标志物 https://news.medxy.ai/ja/soluble-bcma-myeloma/Medxy AIja2026-09-26T06:49:02-07:00新規診断多発性骨髄腫における腫瘍フェノタイプと予後を規定する鍵：可溶性BCMA https://news.medxy.ai/vi/sbcmadissoluble-biomarker-tumor-myeloma/Medxy AIvi2026-09-26T06:48:42-07:00sBCMA hòa tan: Dấu ấn sinh học then chốt định nghĩa kiểu hình khối u và tiên lượng trong đa u tủy mới chẩn đoán https://news.medxy.ai/soluble-bcma-as-a-key-biomarker-defining-tumor-phenotypes-and-prognosis-in-newly-diagnosed-multiple-myeloma/Medxy AIen2026-09-26T06:48:21-07:00Soluble BCMA as a Key Biomarker Defining Tumor Phenotypes and Prognosis in Newly Diagnosed Multiple Myeloma https://news.medxy.ai/zh/ml-weight-loss-risk/Medxy AIzh2026-09-26T06:47:32-07:00解读型机器学习助力减重手术候选者肥胖低通气综合征个体化风险预测 https://news.medxy.ai/ja/personalized-ohs-risk-prediction/Medxy AIja2026-09-26T06:47:13-07:00肥満手術候補患者における個別化OHSリスク予測を実現する説明可能機械学習 https://news.medxy.ai/vi/obesity-ventilation-risk-prediction/Medxy AIvi2026-09-26T06:46:52-07:00Dự báo nguy cơ hội chứng giảm thông khí do béo phì cá thể hóa ở ứng viên phẫu thuật bariatric bằng học máy có khả năng giải thích https://news.medxy.ai/harnessing-explainable-machine-learning-for-personalized-obesity-hypoventilation-syndrome-risk-prediction-in-bariatric-surgery-candidates/Medxy AIen2026-09-26T06:46:32-07:00Harnessing Explainable Machine Learning for Personalized Obesity Hypoventilation Syndrome Risk Prediction in Bariatric Surgery Candidates https://news.medxy.ai/zh/igg-dynamics-monitoring/Medxy AIzh2026-09-26T06:45:44-07:00时间标准化抗曲霉菌IgG动态：监测慢性肺曲霉病进展的新工具 https://news.medxy.ai/ja/chronic-aspergillosis-monitoring/Medxy AIja2026-09-26T06:45:24-07:00時間正規化抗Aspergillus IgG動態による新たな慢性肺アスペルギルス症モニタリング指標 https://news.medxy.ai/vi/igg-kinetics-aspergillus/Medxy AIvi2026-09-26T06:45:02-07:00Động học IgG kháng Aspergillus được chuẩn hóa theo thời gian: công cụ mới để theo dõi tiến triển aspergillosis phổi mạn tính https://news.medxy.ai/time-normalized-anti-aspergillus-igg-kinetics-a-novel-tool-to-monitor-chronic-pulmonary-aspergillosis-progression/Medxy AIen2026-09-26T06:44:44-07:00Time-Normalized Anti-Aspergillus IgG Kinetics: A Novel Tool to Monitor Chronic Pulmonary Aspergillosis Progression https://news.medxy.ai/zh/cftr-antibiotics-impact/Medxy AIzh2026-09-26T06:44:04-07:00CFTR调节剂时代吸入抗生素对囊性纤维化肺功能影响的变化 https://news.medxy.ai/ja/77879-2/Medxy AIja2026-09-26T06:43:48-07:00CFTR調節薬の時代における、嚢胞性線維症の肺機能に対する吸入抗菌薬の影響の変化 https://news.medxy.ai/vi/77878-2/Medxy AIvi2026-09-26T06:43:28-07:00Những thay đổi về tác động của thuốc kháng sinh dạng hít đối với chức năng phổi ở bệnh xơ nang https://news.medxy.ai/evolving-impact-of-inhaled-antibiotics-on-lung-function-in-cystic-fibrosis-during-the-cftr-modulator-era/Medxy AIen2026-09-26T06:43:09-07:00Evolving Impact of Inhaled Antibiotics on Lung Function in Cystic Fibrosis During the CFTR-Modulator Era https://news.medxy.ai/zh/copd-spray-cb/Medxy AIzh2026-09-26T06:42:27-07:00创新性冷冻喷雾治疗为 COPD 合并慢性支气管炎带来新希望：SPRAY-CB 试验解读 https://news.medxy.ai/ja/copd-cryospray-treatment/Medxy AIja2026-09-26T06:42:08-07:00COPDの慢性気管支炎に新たな可能性：SPRAY-CB試験が示したクリオスプレー治療の有望性 https://news.medxy.ai/vi/cryospray-copd-treatment/Medxy AIvi2026-09-26T06:41:51-07:00Cryospray nitơ lỏng sáng tạo cho thấy triển vọng trong điều trị viêm phế quản mạn tính ở bệnh nhân COPD: Góc nhìn từ thử nghiệm SPRAY-CB https://news.medxy.ai/innovative-cryospray-therapy-shows-promise-for-chronic-bronchitis-in-copd-patients-insights-from-the-spray-cb-trial/Medxy AIen2026-09-26T06:41:33-07:00Innovative Cryospray Therapy Shows Promise for Chronic Bronchitis in COPD Patients: Insights from the SPRAY-CB Trial https://news.medxy.ai/zh/77870-2/Medxy AIzh2026-09-26T06:40:53-07:00按吸烟状况分析重症哮喘患者使用生物制剂的转归：来自SHARP欧洲注册研究的启示 https://news.medxy.ai/ja/severe-asthma-treatment/Medxy AIja2026-09-26T06:40:31-07:00喫煙状況別にみた重症喘息における生物学的製剤の転帰：SHARP欧州レジストリからの示唆 https://news.medxy.ai/vi/biologic-therapy-severe-asthma/Medxy AIvi2026-09-26T06:40:07-07:00Kết cục của liệu pháp sinh học ở hen nặng theo tình trạng hút thuốc: Góc nhìn từ Sổ đăng ký SHARP châu Âu https://news.medxy.ai/biologic-outcomes-in-severe-asthma-by-smoking-status-insights-from-the-sharp-european-registry/Medxy AIen2026-09-26T06:39:45-07:00Biologic Outcomes in Severe Asthma by Smoking Status: Insights from the SHARP European Registry https://news.medxy.ai/zh/77865-2/Medxy AIzh2026-09-26T06:38:56-07:00结膜黑色素细胞病变的治疗优化：分阶段多维治疗框架 https://news.medxy.ai/ja/conjunctival-melanocytic-lesion-treatment/Medxy AIja2026-09-26T06:38:34-07:00結膜メラノサイト性病変の治療最適化：段階的多角的治療フレームワーク https://news.medxy.ai/vi/optimized-pigment-lesion-treatment/Medxy AIvi2026-09-26T06:38:14-07:00Tối ưu hóa điều trị các tổn thương sắc tố tế bào hắc tố ở kết mạc: khung điều trị đa mô thức theo trình tự https://news.medxy.ai/optimizing-management-of-conjunctival-melanocytic-lesions-a-sequential-multimodal-treatment-framework/Medxy AIen2026-09-26T06:37:54-07:00Optimizing Management of Conjunctival Melanocytic Lesions: A Sequential Multimodal Treatment Framework https://news.medxy.ai/zh/children-nosebleeds-winter/Medxy AIzh2026-09-26T06:37:14-07:00儿童鼻出血真的更爱“冬天发作”吗？一项持续10年的中大西洋地区研究给出新答案 https://news.medxy.ai/ja/pediatric-nosebleeds/Medxy AIja2026-09-26T06:36:55-07:00小児鼻出血の季節性を再検証する：中部大西洋地域における10年間の研究 https://news.medxy.ai/vi/nosebleeds-children-seasonal/Medxy AIvi2026-09-26T06:36:36-07:00Chảy máu mũi ở trẻ em theo mùa: Phân tích hồi cứu kéo dài 10 năm tại vùng Mid-Atlantic https://news.medxy.ai/re-examining-the-seasonal-pattern-of-pediatric-epistaxis-a-decade-long-mid-atlantic-study/Medxy AIen2026-09-26T06:36:16-07:00Re-examining the Seasonal Pattern of Pediatric Epistaxis: A Decade-Long Mid-Atlantic Study https://news.medxy.ai/zh/laryngeal-chondrosarcoma-outcomes/Medxy AIzh2026-09-26T06:35:37-07:00喉软骨肉瘤的长期气道结局与死亡风险：保留功能与肿瘤控制如何平衡 https://news.medxy.ai/ja/77854-2/Medxy AIja2026-09-26T06:35:20-07:00喉軟骨肉腫における長期的な気道転帰と死亡リスク：機能温存と腫瘍制御のバランスをどうとるか